Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tyrosine kinase inhibitor levels matter in treating chronic GVHD.
van der Wagen L, Janssen J, Raijmakers R, Petersen E, de Witte M, de Jong N, Bellido M, Meijer E, Bär B, Jan Boelens J, Huitema A, Kuball J. van der Wagen L, et al. Among authors: jan boelens j. Bone Marrow Transplant. 2019 Jul;54(7):1141-1144. doi: 10.1038/s41409-018-0429-5. Epub 2019 Jan 16. Bone Marrow Transplant. 2019. PMID: 30651587 Clinical Trial. No abstract available.
Efficacy of MSC for steroid-refractory acute GVHD associates with MSC donor age and a defined molecular profile.
van der Wagen LE, Miranda-Bedate A, Janssen A, Fernando F, Appukudige N, van Dooremalen S, Westinga K, Admiraal R, Lorenowicz MJ, Huls G, Janssen JJWM, Broers AEC, van der Velden WJFM, van Marwijk Kooy R, Hazenberg MD, de Haar C, Lindemans C, Jan Boelens J, Kuball J. van der Wagen LE, et al. Among authors: jan boelens j. Bone Marrow Transplant. 2020 Nov;55(11):2188-2192. doi: 10.1038/s41409-020-0910-9. Epub 2020 Apr 28. Bone Marrow Transplant. 2020. PMID: 32346077 No abstract available.
Low toxicity and favorable overall survival in relapsed/refractory B-ALL following CAR T cells and CD34-selected T-cell depleted allogeneic hematopoietic cell transplant.
Fabrizio VA, Kernan NA, Boulad F, Cancio M, Allen J, Higman M, Margossian SP, Mauguen A, Prockop S, Scaradavou A, Shah N, Spitzer B, Stieglitz E, Yeager N, O'Reilly RJ, Brentjens RJ, Jan Boelens J, Curran KJ. Fabrizio VA, et al. Among authors: jan boelens j. Bone Marrow Transplant. 2020 Nov;55(11):2160-2169. doi: 10.1038/s41409-020-0926-1. Epub 2020 May 10. Bone Marrow Transplant. 2020. PMID: 32390002 Free PMC article.
Lymphoid and myeloid immune cell reconstitution after nicotinamide-expanded cord blood transplantation.
de Koning C, Tao W, Lacna A, van Veghel K, Horwitz ME, Sanz G, Jagasia MH, Wagner JE, Stiff PJ, Hanna R, Cilloni D, Valcárcel D, Peled T, Galamidi Cohen E, Goshen U, Pandit A, Lindemans CA, Jan Boelens J, Nierkens S. de Koning C, et al. Among authors: jan boelens j. Bone Marrow Transplant. 2021 Nov;56(11):2826-2833. doi: 10.1038/s41409-021-01417-4. Epub 2021 Jul 26. Bone Marrow Transplant. 2021. PMID: 34312498 Free PMC article. Clinical Trial.
How to define and measure thymopoiesis after transplantation?
de Koning C, Nierkens S, Jan Boelens J. de Koning C, et al. Among authors: jan boelens j. Bone Marrow Transplant. 2018 Oct;53(10):1364-1365. doi: 10.1038/s41409-018-0199-0. Epub 2018 May 3. Bone Marrow Transplant. 2018. PMID: 29725110 No abstract available.